Jaguar Health Inc. (JAGX)
Jaguar Health Statistics
Share Statistics
Jaguar Health has 656.09K shares outstanding. The number of shares has increased by -86.58% in one year.
| Shares Outstanding | 656.09K |
| Shares Change (YoY) | -86.58% |
| Shares Change (QoQ) | 39.02% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 543.78K |
| Failed to Deliver (FTD) Shares | 6.27K |
| FTD / Avg. Volume | 25.93% |
Short Selling Information
The latest short interest is 332.32K, so 2.82% of the outstanding shares have been sold short.
| Short Interest | 332.32K |
| Short % of Shares Out | 2.82% |
| Short % of Float | 3.23% |
| Short Ratio (days to cover) | 1.12 |
Valuation Ratios
The PE ratio is -193.21 and the forward PE ratio is -0.46. Jaguar Health's PEG ratio is 1.93.
| PE Ratio | -193.21 |
| Forward PE | -0.46 |
| PS Ratio | 643.34 |
| Forward PS | 0.1 |
| PB Ratio | 1145.21 |
| P/FCF Ratio | -253.1 |
| PEG Ratio | 1.93 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Jaguar Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 5.62.
| Current Ratio | 1.63 |
| Quick Ratio | 1.11 |
| Debt / Equity | 5.62 |
| Debt / EBITDA | -1.18 |
| Debt / FCF | -1.24 |
| Interest Coverage | 133.47 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $235.92K |
| Profits Per Employee | $-785.55K |
| Employee Count | 49 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.19 |
Taxes
| Income Tax | -759K |
| Effective Tax Rate | 1.93% |
Stock Price Statistics
The stock price has increased by -87.27% in the last 52 weeks. The beta is 0.81, so Jaguar Health's price volatility has been higher than the market average.
| Beta | 0.81 |
| 52-Week Price Change | -87.27% |
| 50-Day Moving Average | 15.82 |
| 200-Day Moving Average | 25.34 |
| Relative Strength Index (RSI) | 20.62 |
| Average Volume (20 Days) | 24.19K |
Income Statement
In the last 12 months, Jaguar Health had revenue of 11.56M and earned -38.49M in profits. Earnings per share was -0.13.
| Revenue | 11.56M |
| Gross Profit | 9.61M |
| Operating Income | -30.83M |
| Net Income | -38.49M |
| EBITDA | -30.83M |
| EBIT | -39.48M |
| Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 8M in cash and 36.53M in debt, giving a net cash position of -28.52M.
| Cash & Cash Equivalents | 8M |
| Total Debt | 36.53M |
| Net Cash | -28.52M |
| Retained Earnings | -346.48M |
| Total Assets | 58.47M |
| Working Capital | 16.77M |
Cash Flow
In the last 12 months, operating cash flow was -29.38M and capital expenditures 0, giving a free cash flow of -29.38M.
| Operating Cash Flow | -29.38M |
| Capital Expenditures | 0 |
| Free Cash Flow | -29.38M |
| FCF Per Share | -0.1 |
Margins
Gross margin is 83.09%, with operating and profit margins of -266.7% and -332.98%.
| Gross Margin | 83.09% |
| Operating Margin | -266.7% |
| Pretax Margin | -339.54% |
| Profit Margin | -332.98% |
| EBITDA Margin | -266.7% |
| EBIT Margin | -266.7% |
| FCF Margin | -254.19% |
Dividends & Yields
JAGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for JAGX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 24, 2025. It was a backward split with a ratio of 1:25.
| Last Split Date | Mar 24, 2025 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -9.32 |
| Piotroski F-Score | 5 |